We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of secondary surgery in recurrent ovarian cancer.
- Authors
Lorusso, D; Mancini, M; Di Rocco, R; Fontanelli, R; Raspagliesi, F
- Abstract
Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent disease is controversial and remains a field of discussion mainly owing to missing data from prospective randomized trials. A critical review of literature evidence on secondary surgery in recurrent ovarian cancer will be described.
- Publication
International journal of surgical oncology, 2012, Vol 2012, p613980
- ISSN
2090-1410
- Publication type
Journal Article
- DOI
10.1155/2012/613980